Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphedema | 47 | 2024 | 525 | 18.130 |
Why?
|
Lymphatic Vessels | 25 | 2024 | 358 | 11.170 |
Why?
|
Lymph Node Excision | 16 | 2023 | 1271 | 3.600 |
Why?
|
Microsurgery | 14 | 2023 | 795 | 3.060 |
Why?
|
Free Tissue Flaps | 12 | 2022 | 331 | 2.480 |
Why?
|
Lymphatic System | 7 | 2024 | 254 | 2.360 |
Why?
|
Integrative Medicine | 4 | 2020 | 87 | 2.350 |
Why?
|
Surgery, Plastic | 8 | 2024 | 643 | 2.340 |
Why?
|
Lymphography | 13 | 2024 | 188 | 2.320 |
Why?
|
Breast Neoplasms | 33 | 2024 | 21012 | 2.290 |
Why?
|
Epigastric Arteries | 6 | 2021 | 92 | 2.090 |
Why?
|
Lipectomy | 3 | 2023 | 113 | 2.070 |
Why?
|
Lymph Nodes | 16 | 2024 | 3466 | 1.920 |
Why?
|
Mastectomy | 15 | 2023 | 1822 | 1.920 |
Why?
|
Axilla | 14 | 2024 | 624 | 1.790 |
Why?
|
Indocyanine Green | 8 | 2024 | 233 | 1.750 |
Why?
|
Omentum | 3 | 2023 | 168 | 1.380 |
Why?
|
Facial Neoplasms | 3 | 2015 | 125 | 1.240 |
Why?
|
Mammaplasty | 9 | 2021 | 1239 | 1.230 |
Why?
|
Neurofibromatoses | 3 | 2013 | 299 | 0.940 |
Why?
|
Arm | 5 | 2023 | 589 | 0.930 |
Why?
|
Microdissection | 2 | 2015 | 151 | 0.910 |
Why?
|
Musculoskeletal Diseases | 3 | 2019 | 598 | 0.900 |
Why?
|
Lower Extremity | 7 | 2023 | 1202 | 0.900 |
Why?
|
Rectus Abdominis | 2 | 2015 | 103 | 0.890 |
Why?
|
Dissection | 2 | 2015 | 298 | 0.870 |
Why?
|
Comprehension | 3 | 2019 | 621 | 0.840 |
Why?
|
Health Literacy | 3 | 2019 | 444 | 0.840 |
Why?
|
Insurance | 1 | 2023 | 113 | 0.800 |
Why?
|
Facial Transplantation | 3 | 2021 | 221 | 0.790 |
Why?
|
Occupational Diseases | 3 | 2019 | 1490 | 0.770 |
Why?
|
Upper Extremity | 9 | 2023 | 657 | 0.760 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2023 | 385 | 0.680 |
Why?
|
Vascular Surgical Procedures | 4 | 2024 | 1489 | 0.670 |
Why?
|
Anastomosis, Surgical | 6 | 2022 | 983 | 0.670 |
Why?
|
Homeopathy | 1 | 2019 | 30 | 0.650 |
Why?
|
Acupuncture Therapy | 1 | 2023 | 486 | 0.620 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2022 | 156 | 0.600 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2018 | 198 | 0.600 |
Why?
|
Consumer Health Information | 2 | 2017 | 215 | 0.580 |
Why?
|
Internet | 3 | 2019 | 3092 | 0.570 |
Why?
|
Sentinel Lymph Node Biopsy | 4 | 2023 | 732 | 0.570 |
Why?
|
Education, Medical, Graduate | 2 | 2019 | 2373 | 0.550 |
Why?
|
Fluorescein | 1 | 2017 | 175 | 0.550 |
Why?
|
Facial Bones | 2 | 2018 | 208 | 0.540 |
Why?
|
Humans | 107 | 2024 | 761504 | 0.540 |
Why?
|
Tissue Expansion | 3 | 2017 | 160 | 0.520 |
Why?
|
Mind-Body Therapies | 1 | 2019 | 279 | 0.510 |
Why?
|
Taxoids | 1 | 2019 | 668 | 0.510 |
Why?
|
Female | 71 | 2024 | 392644 | 0.500 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2015 | 239 | 0.500 |
Why?
|
Whole Blood Coagulation Time | 1 | 2015 | 30 | 0.490 |
Why?
|
Coloring Agents | 3 | 2022 | 562 | 0.480 |
Why?
|
Intraoperative Care | 2 | 2017 | 767 | 0.480 |
Why?
|
Models, Animal | 2 | 2018 | 2112 | 0.470 |
Why?
|
Quality of Life | 8 | 2024 | 13367 | 0.460 |
Why?
|
Soft Tissue Neoplasms | 2 | 2013 | 1159 | 0.450 |
Why?
|
Postoperative Complications | 11 | 2022 | 15631 | 0.450 |
Why?
|
Retrospective Studies | 31 | 2023 | 80636 | 0.430 |
Why?
|
Muscle Neoplasms | 1 | 2014 | 130 | 0.430 |
Why?
|
Skull Neoplasms | 1 | 2013 | 173 | 0.410 |
Why?
|
Middle Aged | 45 | 2023 | 220895 | 0.410 |
Why?
|
Sacrum | 1 | 2014 | 276 | 0.410 |
Why?
|
Enoxaparin | 1 | 2015 | 391 | 0.410 |
Why?
|
Scalp | 1 | 2015 | 389 | 0.400 |
Why?
|
Thrombophilia | 1 | 2015 | 305 | 0.400 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1069 | 0.400 |
Why?
|
Medical Informatics | 1 | 2019 | 733 | 0.390 |
Why?
|
Blood Coagulation | 2 | 2015 | 1154 | 0.370 |
Why?
|
Skull | 1 | 2015 | 818 | 0.360 |
Why?
|
Head | 2 | 2018 | 924 | 0.360 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 5492 | 0.350 |
Why?
|
Treatment Outcome | 22 | 2023 | 64680 | 0.350 |
Why?
|
Facial Nerve | 1 | 2012 | 277 | 0.340 |
Why?
|
Lymphatic Metastasis | 4 | 2021 | 2915 | 0.340 |
Why?
|
Referral and Consultation | 3 | 2024 | 3600 | 0.310 |
Why?
|
Microvessels | 1 | 2012 | 577 | 0.300 |
Why?
|
Attitude to Health | 1 | 2017 | 2025 | 0.300 |
Why?
|
General Surgery | 1 | 2019 | 1692 | 0.290 |
Why?
|
Heparin | 1 | 2015 | 1634 | 0.290 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 561 | 0.280 |
Why?
|
Adult | 33 | 2024 | 221177 | 0.280 |
Why?
|
Aged | 27 | 2023 | 169289 | 0.270 |
Why?
|
Surgical Flaps | 6 | 2018 | 1671 | 0.260 |
Why?
|
Wound Healing | 2 | 2015 | 2805 | 0.250 |
Why?
|
Swine | 3 | 2022 | 5915 | 0.240 |
Why?
|
Breast Implants | 3 | 2017 | 411 | 0.240 |
Why?
|
Pilot Projects | 3 | 2023 | 8631 | 0.220 |
Why?
|
Decision Trees | 2 | 2021 | 504 | 0.210 |
Why?
|
Esthetics | 2 | 2015 | 330 | 0.210 |
Why?
|
Incidence | 5 | 2022 | 21353 | 0.200 |
Why?
|
Databases, Factual | 6 | 2019 | 7967 | 0.200 |
Why?
|
Male | 33 | 2024 | 360804 | 0.200 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2529 | 0.200 |
Why?
|
Follow-Up Studies | 10 | 2023 | 39106 | 0.200 |
Why?
|
Chronic Disease | 3 | 2022 | 9318 | 0.190 |
Why?
|
Cerebrospinal Fluid | 1 | 2024 | 544 | 0.180 |
Why?
|
Eyelids | 2 | 2013 | 278 | 0.180 |
Why?
|
Postoperative Care | 3 | 2019 | 1468 | 0.180 |
Why?
|
Intraoperative Period | 2 | 2018 | 510 | 0.180 |
Why?
|
Elbow | 1 | 2021 | 130 | 0.180 |
Why?
|
Transplantation, Autologous | 2 | 2015 | 2115 | 0.180 |
Why?
|
Neck | 2 | 2015 | 734 | 0.170 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2013 | 1875 | 0.170 |
Why?
|
Axillary Vein | 1 | 2019 | 14 | 0.170 |
Why?
|
Rosaniline Dyes | 1 | 2019 | 50 | 0.170 |
Why?
|
Donor Selection | 2 | 2012 | 232 | 0.170 |
Why?
|
Tissue Expansion Devices | 2 | 2017 | 156 | 0.170 |
Why?
|
Insurance Coverage | 2 | 2023 | 1940 | 0.170 |
Why?
|
Policy | 1 | 2023 | 508 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4026 | 0.160 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2019 | 223 | 0.160 |
Why?
|
Ion Channels | 1 | 2024 | 1040 | 0.160 |
Why?
|
Anticoagulants | 1 | 2015 | 4812 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2022 | 588 | 0.160 |
Why?
|
Lymphatic Diseases | 1 | 2021 | 320 | 0.160 |
Why?
|
Skin Pigmentation | 1 | 2021 | 277 | 0.160 |
Why?
|
United States | 12 | 2023 | 72334 | 0.160 |
Why?
|
Plants, Medicinal | 1 | 2019 | 165 | 0.160 |
Why?
|
Veins | 1 | 2022 | 768 | 0.150 |
Why?
|
Career Choice | 1 | 2024 | 756 | 0.150 |
Why?
|
Breast Implantation | 2 | 2017 | 223 | 0.150 |
Why?
|
Cultural Characteristics | 1 | 2019 | 251 | 0.140 |
Why?
|
Isothiocyanates | 1 | 2017 | 49 | 0.140 |
Why?
|
Buttocks | 2 | 2014 | 111 | 0.140 |
Why?
|
Nitroglycerin | 1 | 2018 | 329 | 0.140 |
Why?
|
Skull Fractures | 1 | 2018 | 202 | 0.140 |
Why?
|
Thrombosis | 1 | 2010 | 2942 | 0.140 |
Why?
|
Breast | 2 | 2023 | 1967 | 0.130 |
Why?
|
Risk Factors | 7 | 2023 | 74206 | 0.130 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 3595 | 0.130 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13639 | 0.130 |
Why?
|
Sharks | 1 | 2015 | 21 | 0.130 |
Why?
|
Florida | 1 | 2017 | 431 | 0.130 |
Why?
|
Graft Survival | 5 | 2018 | 3819 | 0.130 |
Why?
|
Primary Prevention | 1 | 2023 | 1186 | 0.130 |
Why?
|
Vasoconstriction | 1 | 2018 | 592 | 0.120 |
Why?
|
Sex Reassignment Surgery | 1 | 2018 | 164 | 0.120 |
Why?
|
Thoracic Wall | 2 | 2014 | 202 | 0.120 |
Why?
|
Radiotherapy | 1 | 2021 | 1499 | 0.120 |
Why?
|
Efficiency | 1 | 2018 | 476 | 0.120 |
Why?
|
Bites and Stings | 1 | 2015 | 93 | 0.120 |
Why?
|
Muscle Contraction | 1 | 2019 | 1201 | 0.120 |
Why?
|
Leg | 1 | 2019 | 1088 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2002 | 1374 | 0.120 |
Why?
|
Hidradenitis Suppurativa | 1 | 2018 | 178 | 0.120 |
Why?
|
Calciphylaxis | 1 | 2016 | 130 | 0.120 |
Why?
|
Video Recording | 1 | 2019 | 966 | 0.120 |
Why?
|
Goals | 1 | 2019 | 711 | 0.120 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2018 | 303 | 0.120 |
Why?
|
Thrombophlebitis | 1 | 2015 | 289 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 8 | 2023 | 36426 | 0.110 |
Why?
|
Nasal Cartilages | 1 | 2013 | 14 | 0.110 |
Why?
|
Consensus | 1 | 2023 | 3123 | 0.110 |
Why?
|
Phyllodes Tumor | 1 | 2014 | 53 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 2 | 2015 | 8181 | 0.110 |
Why?
|
Cheek | 1 | 2013 | 65 | 0.110 |
Why?
|
Thrombocythemia, Essential | 1 | 2015 | 113 | 0.110 |
Why?
|
Research Support as Topic | 1 | 2018 | 697 | 0.110 |
Why?
|
Back | 1 | 2013 | 64 | 0.110 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2850 | 0.110 |
Why?
|
Vasodilator Agents | 1 | 2018 | 973 | 0.110 |
Why?
|
Nose Deformities, Acquired | 1 | 2013 | 44 | 0.110 |
Why?
|
Prognosis | 3 | 2019 | 29625 | 0.110 |
Why?
|
Mandibular Fractures | 1 | 2013 | 76 | 0.110 |
Why?
|
Mandibular Condyle | 1 | 2013 | 115 | 0.110 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2013 | 55 | 0.110 |
Why?
|
Breast Diseases | 1 | 2016 | 442 | 0.110 |
Why?
|
Prevalence | 3 | 2019 | 15732 | 0.110 |
Why?
|
Mandibular Advancement | 1 | 2013 | 64 | 0.110 |
Why?
|
Microscopy | 1 | 2018 | 903 | 0.110 |
Why?
|
Lymphangioma | 1 | 2013 | 61 | 0.110 |
Why?
|
Animals | 8 | 2024 | 168459 | 0.110 |
Why?
|
Retrobulbar Hemorrhage | 1 | 2012 | 10 | 0.100 |
Why?
|
Cohort Studies | 6 | 2019 | 41487 | 0.100 |
Why?
|
Needs Assessment | 1 | 2019 | 1139 | 0.100 |
Why?
|
Obturator Nerve | 1 | 2012 | 11 | 0.100 |
Why?
|
Multiple Trauma | 1 | 2015 | 369 | 0.100 |
Why?
|
Observer Variation | 1 | 2019 | 2606 | 0.100 |
Why?
|
Health Resources | 1 | 2019 | 935 | 0.100 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8529 | 0.100 |
Why?
|
Abdomen | 1 | 2018 | 1128 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2019 | 942 | 0.100 |
Why?
|
Demography | 1 | 2017 | 1648 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26125 | 0.100 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1432 | 0.100 |
Why?
|
Lip | 1 | 2013 | 197 | 0.100 |
Why?
|
Vena Cava Filters | 1 | 2015 | 261 | 0.100 |
Why?
|
Face | 1 | 2018 | 1026 | 0.100 |
Why?
|
Fascia | 1 | 2012 | 140 | 0.100 |
Why?
|
Internship and Residency | 2 | 2024 | 5880 | 0.100 |
Why?
|
Prospective Studies | 5 | 2023 | 54425 | 0.100 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1165 | 0.090 |
Why?
|
Skin Transplantation | 2 | 2017 | 1083 | 0.090 |
Why?
|
Thoracic Neoplasms | 1 | 2013 | 267 | 0.090 |
Why?
|
Orbital Fractures | 1 | 2012 | 109 | 0.090 |
Why?
|
Perioperative Care | 1 | 2019 | 1033 | 0.090 |
Why?
|
Students, Medical | 1 | 2024 | 1936 | 0.090 |
Why?
|
Publishing | 1 | 2018 | 833 | 0.090 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18252 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2019 | 6228 | 0.090 |
Why?
|
Surgery Department, Hospital | 1 | 2012 | 176 | 0.090 |
Why?
|
Vulvar Neoplasms | 1 | 2013 | 263 | 0.090 |
Why?
|
Hemostasis, Surgical | 1 | 2010 | 126 | 0.090 |
Why?
|
Facial Injuries | 1 | 2012 | 190 | 0.090 |
Why?
|
Mandible | 1 | 2015 | 753 | 0.090 |
Why?
|
Adolescent | 8 | 2017 | 88319 | 0.090 |
Why?
|
Software | 1 | 2024 | 4434 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1520 | 0.090 |
Why?
|
Organizational Objectives | 1 | 2012 | 426 | 0.080 |
Why?
|
Hospitals, Urban | 1 | 2012 | 500 | 0.080 |
Why?
|
Forecasting | 1 | 2019 | 2928 | 0.080 |
Why?
|
Information Dissemination | 1 | 2018 | 1126 | 0.080 |
Why?
|
Orbit | 1 | 2013 | 457 | 0.080 |
Why?
|
Ischemia | 1 | 2018 | 1882 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2319 | 0.080 |
Why?
|
Temporal Bone | 1 | 2013 | 683 | 0.080 |
Why?
|
Cytokines | 1 | 2023 | 7396 | 0.070 |
Why?
|
Carcinoma, Basal Cell | 1 | 2013 | 560 | 0.070 |
Why?
|
Water | 1 | 2014 | 1411 | 0.070 |
Why?
|
Osteotomy | 1 | 2013 | 837 | 0.070 |
Why?
|
Hemangioma | 1 | 2013 | 727 | 0.070 |
Why?
|
Pain | 1 | 2023 | 5073 | 0.070 |
Why?
|
Hematoma | 1 | 2012 | 768 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2019 | 20570 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58976 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3688 | 0.070 |
Why?
|
Graft Rejection | 2 | 2021 | 4445 | 0.070 |
Why?
|
Periodicals as Topic | 1 | 2018 | 1463 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3357 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3461 | 0.070 |
Why?
|
Image Enhancement | 1 | 2017 | 2885 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3424 | 0.070 |
Why?
|
Insurance, Health | 1 | 2018 | 2498 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2012 | 1440 | 0.060 |
Why?
|
Informed Consent | 1 | 2012 | 1008 | 0.060 |
Why?
|
HIV-1 | 1 | 2002 | 6863 | 0.060 |
Why?
|
Embolization, Therapeutic | 2 | 2012 | 1418 | 0.060 |
Why?
|
Bibliometrics | 2 | 2018 | 352 | 0.060 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2005 | 140 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3205 | 0.060 |
Why?
|
Thiadiazoles | 1 | 2024 | 63 | 0.060 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2003 | 45 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20098 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2012 | 4806 | 0.050 |
Why?
|
Venous Thromboembolism | 2 | 2018 | 1866 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3429 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6485 | 0.050 |
Why?
|
Ultrasonography | 1 | 2015 | 5972 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3358 | 0.050 |
Why?
|
Meninges | 1 | 2024 | 198 | 0.050 |
Why?
|
Groin | 1 | 2022 | 106 | 0.050 |
Why?
|
Costs and Cost Analysis | 2 | 2017 | 1668 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15842 | 0.050 |
Why?
|
Homeostasis | 1 | 2012 | 3323 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2002 | 318 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2002 | 9031 | 0.050 |
Why?
|
Patient Care Team | 1 | 2012 | 2521 | 0.040 |
Why?
|
Burns | 1 | 2012 | 1882 | 0.040 |
Why?
|
Cytarabine | 1 | 2002 | 697 | 0.040 |
Why?
|
Child | 3 | 2013 | 80153 | 0.040 |
Why?
|
Vincristine | 1 | 2002 | 1036 | 0.040 |
Why?
|
Edema | 1 | 2023 | 766 | 0.040 |
Why?
|
Mechanotransduction, Cellular | 1 | 2024 | 529 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14031 | 0.040 |
Why?
|
Patient Selection | 1 | 2011 | 4244 | 0.040 |
Why?
|
Boston | 1 | 2012 | 9326 | 0.040 |
Why?
|
Reoperation | 3 | 2018 | 4303 | 0.040 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2002 | 646 | 0.040 |
Why?
|
Papaverine | 1 | 2018 | 45 | 0.040 |
Why?
|
Pyrazines | 1 | 2024 | 1201 | 0.040 |
Why?
|
Rats | 1 | 2014 | 23742 | 0.040 |
Why?
|
Program Development | 1 | 2024 | 1297 | 0.040 |
Why?
|
Medicare | 3 | 2022 | 6770 | 0.040 |
Why?
|
Implant Capsular Contracture | 1 | 2017 | 23 | 0.040 |
Why?
|
Time Factors | 3 | 2017 | 39967 | 0.040 |
Why?
|
Prednisone | 1 | 2002 | 1563 | 0.040 |
Why?
|
Hydrocephalus | 1 | 2024 | 764 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 4948 | 0.040 |
Why?
|
Risk Assessment | 2 | 2015 | 23995 | 0.030 |
Why?
|
Journal Impact Factor | 1 | 2018 | 153 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2002 | 2218 | 0.030 |
Why?
|
Radiosurgery | 1 | 2005 | 1342 | 0.030 |
Why?
|
Industry | 1 | 2018 | 364 | 0.030 |
Why?
|
Administration, Topical | 1 | 2018 | 704 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9280 | 0.030 |
Why?
|
Program Evaluation | 1 | 2024 | 2495 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2021 | 1258 | 0.030 |
Why?
|
Debridement | 1 | 2018 | 494 | 0.030 |
Why?
|
Doxorubicin | 1 | 2002 | 2224 | 0.030 |
Why?
|
Methotrexate | 1 | 2002 | 1719 | 0.030 |
Why?
|
Education, Medical, Undergraduate | 1 | 2024 | 1070 | 0.030 |
Why?
|
Young Adult | 3 | 2024 | 59243 | 0.030 |
Why?
|
Outpatients | 1 | 2023 | 1597 | 0.030 |
Why?
|
Physical Therapy Modalities | 1 | 2018 | 532 | 0.030 |
Why?
|
Indians, North American | 1 | 2018 | 352 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2018 | 793 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2018 | 513 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1722 | 0.030 |
Why?
|
Inguinal Canal | 1 | 2014 | 71 | 0.030 |
Why?
|
Maxillary Fractures | 1 | 2013 | 21 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5821 | 0.030 |
Why?
|
Tamoxifen | 1 | 2018 | 965 | 0.030 |
Why?
|
Necrosis | 1 | 2018 | 1611 | 0.030 |
Why?
|
Spinal Diseases | 1 | 2018 | 564 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2022 | 1527 | 0.030 |
Why?
|
Sternum | 1 | 2013 | 175 | 0.030 |
Why?
|
Cicatrix | 1 | 2018 | 798 | 0.030 |
Why?
|
Drainage | 1 | 2018 | 1157 | 0.030 |
Why?
|
Radial Artery | 1 | 2014 | 187 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 931 | 0.030 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2002 | 1405 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2017 | 1784 | 0.020 |
Why?
|
Clavicle | 1 | 2014 | 224 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2018 | 980 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9539 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2018 | 1298 | 0.020 |
Why?
|
Taiwan | 1 | 2012 | 521 | 0.020 |
Why?
|
Bone Plates | 1 | 2013 | 466 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1496 | 0.020 |
Why?
|
Child, Preschool | 1 | 2013 | 42230 | 0.020 |
Why?
|
Fracture Fixation | 1 | 2012 | 366 | 0.020 |
Why?
|
Arteries | 1 | 2014 | 1123 | 0.020 |
Why?
|
Survival Analysis | 1 | 2002 | 10090 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 1117 | 0.020 |
Why?
|
Preoperative Care | 1 | 2018 | 2242 | 0.020 |
Why?
|
Education, Medical | 1 | 2021 | 1725 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 22170 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2012 | 1045 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2018 | 1879 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2012 | 491 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5871 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1186 | 0.020 |
Why?
|
Fracture Fixation, Internal | 1 | 2013 | 973 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2012 | 816 | 0.020 |
Why?
|
Equipment Design | 1 | 2013 | 3510 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22169 | 0.020 |
Why?
|
Mammography | 1 | 2016 | 2430 | 0.020 |
Why?
|
Comorbidity | 1 | 2018 | 10508 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 1880 | 0.010 |
Why?
|
Biliary Tract | 1 | 2003 | 135 | 0.010 |
Why?
|
Biliary Tract Diseases | 1 | 2003 | 159 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3801 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8654 | 0.010 |
Why?
|
Models, Statistical | 1 | 2017 | 5079 | 0.010 |
Why?
|
Visual Acuity | 1 | 2012 | 2672 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.010 |
Why?
|
Biliary Tract Neoplasms | 1 | 2003 | 185 | 0.010 |
Why?
|
Acute Disease | 1 | 2012 | 7237 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 11742 | 0.010 |
Why?
|
Iatrogenic Disease | 1 | 2003 | 539 | 0.010 |
Why?
|
Skin | 1 | 2013 | 4484 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10552 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7407 | 0.010 |
Why?
|
Mice | 1 | 2024 | 81525 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18395 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2003 | 2330 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2005 | 3979 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2003 | 2491 | 0.010 |
Why?
|